Sino Biological
Latest round
- Series B
Last raised
- Jan 2020
Total raised
- $29M
Investors
- 3
About Sino Biological
Established in 2016 and based in Beijing, China, Sino Biological Inc. operates as a contract research organization (CRO) service provider that focuses on biotechnology. The company has 330 employees and 33% of the core research team has master's degree. The founder, Dr. Liangzhi Xie has undertaken a number of national "863" program, and the national "new drug creation" major special projects. In April 2016, the company's product, SCT400, entered the clinical phase III. Sino Biological provides the R&D, production, sales and technology of biological reagent and pre-clinical scale production service for pharmaceutical company or biotech company. The product of the company includes recombinant protein, antibody, gene and culture medium, such as IL-1 beta primes innate immunity, CD155 and its receptors and common humancoronavirus(HCoV) antigens. The CRO service of the company includes recombinant protein and antibody development and biological analysis and detection. Sino Biological adopts quality control system, such as molecular level testing, basic physical and chemical testing, multiple immunological testing.
Who invested in Sino Biological
3 investors across 2 rounds
See all investors in Sino Biological
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sino Biological
Who invested in Sino Biological?
Sino Biological has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sino Biological raised?
Sino Biological has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Sino Biological last raise money?
Sino Biological's most recent round on record is a Series B, in Jan 2020.
What does Sino Biological do?
Established in 2016 and based in Beijing, China, Sino Biological Inc.
Where is Sino Biological headquartered?
Sino Biological is headquartered in Beijing, China.
Which VCs invest in companies like Sino Biological?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Sino Biological's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Sino Biological? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.